Literature DB >> 660276

ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals.

M E Phelps, E J Hoffman, S C Huang, D E Kuhl.   

Abstract

The ECAT was designed and developed as a positron imaging system capable of providing high contrast, high resolution, quantitative images in two-dimensional (2-D) and tomographic formats. The flexibility in its variety of imaging problems. High (HR), medium (MR), and low (LR) tomographic resolutions are 0.95 +/- 0.1, 1.3 +/- 0.1, and 1.7 +/- 0.1 cm FWHM; high, medium, and low resolutions in 2-D images are 0.85 +/- 0.1, 1.3 +/- 0.1 and 1.7 +/- 0.1, depending on resolution mode employed. ECT system efficiency is 30,100, 15,900, and 9,200 c/sec/muCi/cc with a 20-cm diameter phantom at LR, MR, and HR. Because of the geometric, detector, electronic and shielding design of the system, count-rate capability and linearity are high, with minimum detection of scattered radiation and random coincidence. Measured error agrees well with theoretical statistical predictions down to a level of 1.4% standard deviation. The redundant sampling scheme of this system significantly reduces errors caused by motion and detector instability. Scan times are variable from 10 sec to several min/slice and multiple levels are automatically performed by computer control of patient bed. A variety of human studies illustrate image quality, resolution, and efficiency of both ECT and 2-D imaging mode. Examples of the noninvasive study method have been made possible through development of ECT.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 660276

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  25 in total

Review 1.  Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives.

Authors:  D Visvikis; P J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

2.  RADIONUCLIDE COMPUTED TOMOGRAPHY: APPLICATIONS IN CARDIOVASCULAR DISEASE.

Authors:  Paul H. Murphy; John A. Burdine
Journal:  Cardiovasc Dis       Date:  1979-09

3.  Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.

Authors:  K L Leenders; A J Palmer; N Quinn; J C Clark; G Firnau; E S Garnett; C Nahmias; T Jones; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 4.  PET: a biological imaging technique.

Authors:  M E Phelps
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 5.  The potential of PET/MR for brain imaging.

Authors:  Wolf-Dieter Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

6.  Emission tomography of the heart: principles and applications.

Authors:  J S Zielonka; B L Holman
Journal:  Cardiovasc Radiol       Date:  1979-09

7.  The physical performances of a single slice positron tomographic system and preliminary results in a clinical environment.

Authors:  F Soussaline; A E Todd-Pokropek; D Plummer; D Comar; C Loch; S Houle; C Kellershohn
Journal:  Eur J Nucl Med       Date:  1979-08-01

Review 8.  Positron emission tomography and in vivo measurements of tumour perfusion and oxygen utilisation.

Authors:  A A Lammertsma
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Measurement of regional cerebral blood flow and oxygen utilisation in patients with cerebral tumours using 15O and positron emission tomography: analytical techniques and preliminary results.

Authors:  M Ito; A A Lammertsma; R J Wise; S Bernardi; R S Frackowiak; J D Heather; C G McKenzie; D G Thomas; T Jones
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry.

Authors:  Shuang Hou; Jin-Sil Choi; Mitch Andre Garcia; Yan Xing; Kuan-Ju Chen; Yi-Ming Chen; Ziyue K Jiang; Tracy Ro; Lily Wu; David B Stout; James S Tomlinson; Hao Wang; Kai Chen; Hsian-Rong Tseng; Wei-Yu Lin
Journal:  ACS Nano       Date:  2016-01-12       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.